Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen

Cancer Research

Volumn 59, Issue 2, 1999, Pages 342-346

  Tomoko, Ise ^a   Nagatani, Gunji ^a   Imamura, Toshihiro ^a   Kato, Ken ^a   Takano, Hiroshi ^a   Nomoto, Minoru ^a   Izumi, Hiroto ^a   Ohmori, Haruki ^a   Okamoto, Tatsuro ^b   Ohga, Takefumi ^b   Uchiumi, Takeshi ^b   Kuwano, Michihiko ^b   Kohno, Kimitoshi ^a  

^a UNIVERSITY OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CELL NUCLEUS ANTIGEN; CISPLATIN; GLUTATHIONE TRANSFERASE; HYBRID PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; CANCER CELL CULTURE; DNA REPAIR; ELECTROPHORETIC MOBILITY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DNA BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION;

CCAAT-ENHANCER-BINDING PROTEINS; CISPLATIN; DNA; DNA DAMAGE; DNA REPAIR; DNA-BINDING PROTEINS; HUMANS; KB CELLS; NFI TRANSCRIPTION FACTORS; PROLIFERATING CELL NUCLEAR ANTIGEN; TRANSCRIPTION FACTORS; Y-BOX-BINDING PROTEIN 1;

EID: 0344820727     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Didier, D. K., Schiffenbauer, J., Woulfe, S. L., Zacheis, M., and Schwartz, B. D. Characterization of the cDNA encoding a protein binding to the major histocompatibility complex class II Y box. Proc. Natl. Acad. Sci. USA. 85: 7322-7326, 1988.
2. Wolffe, A. P., Tafuri, S., Ranjan, M., and Familari, M. The Y-box factors: a family of nucleic acid binding proteins conserved from Escherichia coli to man. New Biol., 4: 290-298, 1992.
3. Mantovani, R. A survey of 178 NF-Y binding CCAAT boxes. Nucleic Acids Res., 26: 1135-1143, 1998.
4. Ohga, T., Uchiumi, T., Makino, Y., Koike, K., Wada, M., Kuwano, M., and Kohno, K. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J. Biol. Chem., 273: 5997-6000, 1998.
5. Ohga, T., Koike, K., Ono, M., Makino, Y., Itagaki, Y., Tanimoto, M., Kuwano, M., and Kohno, K. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light. Cancer Res., 56: 4224-4228, 1996.
6. Chu, G. Cellular responses to cisplatin. The roles of DNA binding proteins and DNA repair. J. Biol. Chem., 269: 787-790, 1994.
7. Zamble, D. B., and Lippard, S. J. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem. Sci., 20: 435-439, 1995.
8. Singh, J., and Dixon, G. H. High mobility group proteins land 2 function as general class II transcription factors. Biochemistry, 29: 6295-6302, 1990.
9. Jones, C. J., and Wood, R. D. Preferential binding of the xeroderma pigmentosum group A complementing protein to damaged DNA. Biochemistry, 32: 12096-12104, 1993.
10. Pil, P. M., and Lippard, S. J. Specific binding of chromosomal protein HMG1 to DNA damaged by the anticancer drug cisplatin. Science (Washington DC), 256: 234-237, 1992.
11. Moggs, J. G., Yarema, K. J., Essigmann, J. M., and Wood, R. D. Analysis of incision sites produced by human cell extracts and purified proteins during nucleotide excision repair of a 1,3-intrastrand d(GpTpG)-cisplatin adduct. J. Biol. Chem., 271: 7177-7186, 1996.
12. Landsman, D., and Bustin, M. A signature for the HMG-1 box DNA-binding proteins. Bioessays, 15: 539-546, 1993.
13. Park, C. H., Mu, D., Reardon, J. T., and Sancar, A. The general transcription-repair factor TFIIH is recruited to the excision repair complex by the XPA protein independent of the TFIIE transcription factor. J. Biol. Chem., 270: 4896-4902, 1995.
14. Dignam, J. D., Lenovitz, R. M., and Roeder, R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res., 11: 1475-1489, 1983.
15. Sambrook, J., Fritsch, E. F., and Maniatis, T. Molecular Cloning: A Laboratory Manual, Ed. 2. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
16. Timmer-Bosscha, H., Mulder, N. H., and de Vries, E. G. E. Modulation of cis-diamminedichloroplatinum (II) resistance: a review. Br. J. Cancer, 66: 227-238, 1992.
17. Brown, S. J., Kellett, P. J., and Lippard, S. J. Ixrl, a yeast protein that binds to platinated DNA and confers sensitivity to cisplatin. Science (Washington DC), 261: 603-605, 1993.
18. Hasegawa, S. L., Doetsch, P. W., Hamilton, K. K., Martin, A. M., Okenquist, S A., Lenz, J., and Boss, J. M. DNA binding properties of YB-1 and dbpA: binding to double-stranded, single-stranded, and abasic sites containing DNAs. Nucleic Acids Res., 19: 4915-4920, 1991.
19. Koike, K., Uchiumi, T., Ohga, T., Toh, S., Wada, M., Kohno, K., and Kuwano M. Nuclear translocation of the Y-box binding protein by ultraviolet irradiation. FEBS Lett., 417: 390-394, 1997.
20. Levin, D. S., Bai, W., Yao, N., O'Donnell, M., and Tomkinson, A. E. An interaction between DNA ligase I and proliferating cell nuclear antigen: implications for Okazaki fragment synthesis and joining. Proc. Natl. Acad. Sci. USA, 94: 12863-12868, 1997.
21. Flores-Rozas, H., Kelman, Z., Dean, F. B., Pan, Z-Q., Harper, J. W., Elledge, S. J., O'Donnell, M., and Hurwitz, J. Cdk-interacting protein I directly binds with proliferating cell nuclear antigen and inhibits DNA replication catalyzed by the DNA polymerase δ holoenzyme. Proc. Natl. Acad. Sci. USA. 91: 8655-8659, 1994.
22. WAF1. Science (Washington DC), 277: 1996-2000, 1997.